About ARTBIO
Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize their potential.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $132,000,000 · Series-B
Backed by B Capital
- Capital Raise
Raised $90,000,000 · Series-A
Backed by Third Rock Ventures
- Capital Raise
Raised $23,000,000 · Seed
Backed by F-Prime Capital
- Milestone
Company founded
Cambridge, United States
Investors & Backers
Funding History
Round backers: B Capital
Round backers: Third Rock Ventures
Round backers: F-Prime Capital
Founders & Leadership
Emanuele Ostuni
Founder
Jonathan Freeman
Chief Business Officer
Nick Pullen
Chief Scientific Officer
Øyvind Sverre Bruland
Founder
Roy H. Larsen
Founder
Press Coverage & Sources
fundraisingfox.com/companies/artbio
vcaonline.com/news/2023120706/artbio-raises-oversubscribed-and-upsized-90-million-series-a-financing-to-progress-pipeline-and-isotope-technology-development-for-new-class-of-alpha-radioligand-therapies/
bioworld.com/articles/699253-artbio-raises-23m-to-advance-lead-based-radioligand-therapies-for-prostate-cancer
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Commit Biologics
commitbio.com
Human Biome
human-biome.com
MedInTech
medintech.co.kr
Ace Padel
acepadel.com
Mentix
mentix.world